Skip to main content
. 2019 Jul 12;17:42. doi: 10.1186/s12969-019-0339-0

Table 1.

Population Characteristics, N = 167 (single injection)

N(%) or Median (25th–75th)
All (N = 167) CHOP (N = 72) TSRH (N = 95) P-value SMD
Sex - Female 136 (81%) 58 (81%) 78 (82%) 0.80 0.04
Age, years 6.7 (3.8–10.5) 7.5 (4.8–11.3) 5.6 (3.5–9.8) 0.0416 0.32
Race 0.06 0.36
Black/AA 5 (3%) 2 (3%) 3 (3%)
White 149 (90%) 60 (85%) 89 (94%)
Other 12 (7%) 9 (13%) 3 (3%)
White (vs. nonwhite) 149 (90%) 60 (85%) 89 (94%) 0.0327 0.33
Ethnicity – Hispanic (vs not) 25 (15%) 8 (11%) 17 (18%) 0.25 0.19
Symptom Age Start, yearsa 4.6 (2.3–8.7) 5.7 (3.8–9.8) 3.9 (2.1–8.2) 0.04333 0.35
Knee Symptom Age Start, yearsb 5.6 (3.2–9.7) 6.3 (3.5–10.1) 5.0 (2.9–9.2) 0.43 0.14
Diagnosis age 4.0 (2.5–6.8) 4.8 (2.5–7.5) 3.6 (2.5–6.0) 0.15 0.22
Disease duration, yearsc 0.58 (0.29–2.71) 0.40 (0.22–1.32) 0.74 (0.34–3.09) 0.0141 0.44
Systolic Blood Pressure 106.0 (101.0–115.5) 109.0 (102.0–118.5) 106.0 (100.0–114.0) 0.27 0.19
Diastolic Blood Pressure 63.0 (57.0–66.0) 63.0 (59.0–66.0) 62.0 (57.0–66.0) 0.38 0.15
Iritis – Yesd 4 (4%) 1 (2%) 3 (5%) 1.00 0.11

*Wilcoxon Rank-Sum tests or Chi-squared/Fisher’s Exact Tests between CHOP and TSRH sites, alpha = 0.05

Missing:

aSymptom age start, n = 30 missing

bKnee Symptom age start, n = 33 missing

cDisease duration, n = 38 missing

dIritis, n = 59 missing (35%)

SMD: standardized mean difference. SMD > 0.25 (25%) indicates an imbalance between our groups, P < 0.05 is considered statistically significant (shown in bold)